Form 8-K - Current report:
SEC Accession No. 0000950170-25-035917
Filing Date
2025-03-10
Accepted
2025-03-10 07:40:15
Documents
50
Period of Report
2025-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20250310.htm   iXBRL 8-K 53752
2 EX-99.1 prld-ex99_1.htm EX-99.1 195206
3 EX-99.2 prld-ex99_2.htm EX-99.2 39661
4 GRAPHIC img268059179_0.jpg GRAPHIC 19947
5 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 452283
6 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 686518
7 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 349647
8 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 355479
9 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 536349
10 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 264830
11 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 469036
12 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 317144
13 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 395718
14 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 365172
15 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 404820
16 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 390138
17 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 488277
18 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 484381
19 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 435279
20 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 374205
21 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 395685
22 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 400629
23 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 356001
24 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 439560
25 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 435346
26 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 329634
27 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 398135
28 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 490297
29 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 348387
30 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 483196
31 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 555748
32 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 315359
33 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 413307
34 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 418757
35 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 535712
36 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 449297
37 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 512285
38 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 437984
39 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 314426
40 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 318271
  Complete submission text file 0000950170-25-035917.txt   21309836

Data Files

Seq Description Document Type Size
41 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20250310.xsd EX-101.SCH 50257
52 EXTRACTED XBRL INSTANCE DOCUMENT prld-20250310_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 25722169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)